Quick Links
 

The NIH Director’s Awards: Funding Opportunities Available

The NIH Director’s Awards: Funding Opportunities Available

The NIH Common Fund announces FY2020 funding opportunities for the NIH Director’s Pioneer Award, New Innovator Award, Transformative Research Award, and Early Independence Award in the High-Risk, High-Reward Research program. The program provides unique opportunities for exceptionally creative scientists to pursue highly innovative approaches to address major challenges in biomedical or behavioral research. Any research topic relevant to the broad mission of NIH is welcome. NIH especially encourages applications from women and members of groups that are underrepresented in NIH-funded research.

FY2020 NIH Director’s Pioneer Award (DP1 – Clinical Trial Optional): RFA-RM-19-005

Supports scientists with outstanding records of creativity pursuing new research directions to develop pioneering approaches to major challenges in biomedical and behavioral research.

  • Open to all career stages
  • Single-PI applications only
  • No preliminary data required
  • Must be new scientific research direction
  • $700,000 direct costs per year for 5 years
  • See website for more information and FAQs
  • Q&A Webinar: Wednesday, July 17, 2019 at 3:00 PM EDT. Please register through WebEx and find more info here.
  • Application deadline: September 19, 2019

FY2020 NIH Director’s New Innovator Award (DP2 – Clinical Trial Optional): RFA-RM-19-006

Supports exceptionally creative early career scientists proposing innovative and high-impact projects. Note: The NIH definition of an Early Stage Investigator now includes clinical training.

  • Early Stage Investigators only
  • Single-PI applications only
  • No preliminary data required
  • $1.5 million in direct costs disbursed in first year of 5-year project period
  • See website for more information and FAQs
  • Q&A Webinar: Wednesday, July 17, 2019 at 1:00 PM EDT. Please register through WebEx and find more info here.
  • Application deadline: August 26, 2019

FY2020 NIH Director’s Transformative Research Award (R01 – Clinical Trial Optional): RFA RM-19-007

Supports individuals or teams proposing projects that are inherently risky and untested but have the potential to create or overturn fundamental paradigms.

  • Open to all career stages
  • Open to individuals or teams
  • No preliminary data required
  • Flexible budget
  • See website for more information and FAQs
  • Q&A Webinar: Wednesday, July 24, 2019 at 3:00 PM EDT. Please register through WebEx and find more info here.
  • Application deadline: September 20, 2019

FY2020 NIH Director’s Early Independence Award (DP5 – Clinical Trial Optional): RFA RM-19-008

Supports outstanding junior scientists with the intellect, scientific creativity, drive, and maturity bypass the traditional postdoctoral training period and launch an independent research career. Applicants must have recently completed or will soon complete her/his doctoral degree or clinical training and have the support and guarantee of an independent research position from a host institution.

  • Complete doctoral degree or clinical training between June 1, 2018 and September 30, 2020
  • In non-independent position at time of application
  • Cannot have served in a postdoctoral position more than 12 months following a previous, non-terminal degree
  • Single-PI applications only
  • Requires significant institutional support
  • Limited to two applications per institution
  • No preliminary data required
  • Up to $250,000 direct costs per year for up to 5 years
  • See website for more information and FAQs
  • Q&A Webinar: Wednesday, July 24, 2019 at 1:00 PM EDT. Please register through WebEx and find more info here.
  • Application deadline: September 13, 2019

The High-Risk High-Reward Research Program and other Common Fund programs are managed by the Office of Strategic Coordination, Division of Program Coordination, Planning, and Strategic Initiatives in the NIH Office of the Director, in partnership with the component NIH Institutes, Centers, and Offices. The NIH Common Fund encourages collaboration and supports a series of exceptionally high impact, trans-NIH programs.

The National Institutes of Health (NIH) –“The Nation’s Medical Research Agency” – includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit the NIH website.



NIH Funding Acknowledgment: Important Reminder – Please acknowledge the NIH when publishing papers, patents, projects, and presentations resulting from the use of CTSI resources by including the NIH Funding Acknowledgement.

PARTNERS

VersitiChildren's Hospital of WisconsinVA Medical CenterMarquette UniversityMSOEUWM